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Abstract The apolipoprotein E (apoE) gene promoter
(
 

 
219G/T) polymorphism has been associated with in-
creased risk of myocardial infarction, premature coronary
heart disease, and decreased plasma apoE concentrations. We
examined whether the 
 

 
219G/T polymorphism could mod-
ify the postprandial response of triacylglycerol-rich lipopro-
teins (TRLs). Fifty-one healthy apoE 3/3 male volunteers
(14GG, 29GT, and 8TT) were given a vitamin A fat-loading
test consisting of 1 g of fat/kg body weight and 60,000 IU of
 
vitamin A per m
 
2
 
 of body surface area. Blood samples were
taken at time 0 and every hour until the sixth hour, and every
2 hours and 30 minutes until the eleventh hour. Cholesterol,
triacylglycerols (TGs), and apoE were determined in plasma;
and cholesterol, TG, apoB-100, apoB-48, and retinyl palmitate
(RP) were analyzed in lipoprotein fractions. Postprandial
lipemia data revealed that subjects with the 
 

 
219TT genotype
had a higher postprandial response of large TRL-cholesterol
 
(
 
P
 
 
 

 
 0.03), large TRL-triacylglycerols (
 
P 
 

 
 0.001), large TRL-
RP (
 
P 
 

 
 0.004), and small TRL-apoB-48 (
 
P 
 

 
 0.03) than carri-
ers of the 
 

 
219G allele. Moreover, the 
 

 
219TT subjects had
the lowest postprandial levels of serum apoE (
 
P 
 

 
 0.05).  In
conclusion, the 
 

 
219G/T polymorphism may influence TRL
metabolism during the postprandial period, thus prolonging
postprandial lipemia in subjects with the TT genotype.
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Apolipoprotein E (apoE) is a structural component of
several lipoproteins, including triacylglycerol-rich lipopro-
 
teins (TRLs) and plays an important role in lipid metabo-
lism through the cellular uptake of lipoprotein particles
by lipoprotein receptors in the liver and other tissues (1, 2).
apoE is a polymorphic protein with three common iso-
forms (apoE2, apoE3, and apoE4) that contribute to sus-
ceptibility to atherosclerotic cardiovascular disease (3).
Several matched case control studies have shown a modest
but significant increased prevalence of the 
 
apoE4
 
 allele in
coronary heart disease (CHD) patients from various pop-
ulations (4, 5). Nevertheless, even though the 
 
apoE4
 
 allele
appears to be a significant genetic risk factor for CHD, in-
dividuals with the 
 
apoE4
 
 allele do not inevitably develop
this disorder. This fact suggests that other genetic or envi-
ronmental risk factors may interact with the 
 
apoE
 
 gene in
determining CHD risk. It was recently proposed that to-
gether with the qualitative modification of the apoE
structure due to the 
 
apoE
 
 alleles, quantitative variations of
 
apoE
 
 mRNA expression play a major role in determining
risk (6).
In accordance with this hypothesis, polymorphisms in
the proximal promoter region of the 
 
apoE
 
 gene have re-
cently been described at positions 
 

 
491 A/T, 
 

 
427 T/C,
and 
 

 
219 G/T (7, 8). In particular, there is experimental
evidence, in vitro and in vivo, indicating that the 
 
apoE
 
gene promoter (
 

 
219G/T) polymorphism produces vari-
ations in the transcriptional activity of the gene. Specifi-
cally, the 
 

 
219G allele showed a higher transcriptional ac-
tivity than 
 

 
219T. This effect was probably due to the
differential binding of nuclear proteins, as indicated by
electrophoretic mobility shift assays (7). A study of a Euro-
pean population, including control individuals and multi-
infarct patients, has shown that the 
 
apoE
 
 gene promoter
(
 

 
219G/T) polymorphism is also associated with differ-
ential plasma apoE levels (9), illustrating the fact that this
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polymorphism influences 
 
apoE
 
 expression in vivo. Further-
more, the 
 

 
219T allele is associated with an increased risk
of myocardial infarction (MI) (9) and premature CHD (10).
As a result of eating fat-rich meals, subjects in most in-
dustrialized countries are predominantly in a postpran-
dial state throughout the day. Since 1979, when Zilversmit
(11) proposed that TRL played a role in atherosclerosis,
many research teams have shown the important role of
postprandial lipoprotein particles in the development of
CHD (12–15). In the postprandial state, the hepatic up-
take of TRL, determined by the interaction of the LDL re-
ceptor and the low-density lipoprotein receptor-related
protein with apoE, is one of the main components of this
TRL metabolism.
Thus, a postprandial study design would be the most
suitable procedure for investigating the functional impact
of variation in the 
 
apoE
 
 gene promoter on the catabolism
of TRL. A strong linkage disequilibrium between the
 

 
219T and 
 
apoE4
 
 allele has been described, and 
 
apoE
 
 ge-
notypes have been implicated in a variable postprandial
lipid response (16). Consequently, we have studied the ef-
fect of the 
 
apoE
 
 gene promoter (
 

 
219G/T) polymor-
phism in apoE 3/3 subjects, to the exclusion of other
apoE isoforms. The aim of this study was to determine
whether the 
 
apoE
 
 gene promoter (
 

 
219G/T) polymor-
phism could modify the postprandial response of TRL in
young normolipemic apoE 3/3 males in order to explain
the increased risk of MI and premature CHD associated
with homozygote carriers of the T allele.
MATERIALS AND METHODS
 
Human subjects
 
Fifty-one healthy apoE 3/3 male volunteers (8 with the 
 

 
219TT
genotype, 29 with the 
 

 
219GT genotype, and 14 with the 
 

 
219GG
genotype) were studied. All subjects were students at the Univer-
sity of Cordoba, and all responded to an advertisement. They
ranged in age from 18 to 49 years. None of them had diabetes or
liver, renal, or thyroid disease. None of the subjects were taking
medication or vitamins known to affect plasma lipids, as de-
scribed in our previous studies (17, 18). The subjects’ fasting
plasma lipids, lipoproteins, apolipoprotein concentrations, age,
and body mass indexes are shown in 
 
Table 1
 
. All studies were car-
 
ried out in the research unit at the Hospital Reina Sofia Univer-
sity . The experimental protocol was approved by the Human In-
vestigation Review Committee at the hospital.
 
Vitamin A fat-loading test
 
After a 12 h fast, subjects were given a fatty meal enriched with
60,000 units of vitamin A per m
 
2
 
 of body surface area. The fatty
meal consisted of two cups of whole milk, eggs, bread, bacon,
cream, walnuts, and butter. Subjects were given 1 g of fat and
7 mg of cholesterol per kg of body weight. The meal contained
65% of energy as fat, 15% as protein, and 25% as carbohydrates
and was eaten in 20 min. After the meal, the subjects consumed
no energy for 11 h, but were allowed to drink water. Blood sam-
ples were drawn before the meal, every hour until the sixth hour,
and every 2.5 h until the eleventh hour.
 
Lipoprotein separations
 
Blood was collected in tubes containing EDTA to give a final
concentration of 0.1% EDTA. Plasma was separated from red
blood cells by centrifugation at 1,500 
 
g
 
 for 15 min at 4
 

 
C. The
chylomicron fraction of TRL (large TRL) was isolated from 4 ml
of plasma overlayered with 0.15 mol/l NaCl and 1 mmol/l EDTA
(pH 7.4, d 
 

 
 1.006 kg/l) by a single ultracentrifugal spin (36,200 
 
g
 
,
for 30 min at 4
 

 
C) in a type 50 rotor (Beckman Instruments, Ful-
lerton, CA). Chylomicrons contained in the top layer were re-
moved by aspiration after cutting the tubes. The infranatant
fluid was centrifuged at a density of 1.019 kg/l for 24 h at
183,000 
 
g
 
 in the same rotor. The nonchylomicron fraction (also
referred to as small TRL) was removed from the top of the tube.
All operations were done in subdued light. Large and small TRL
fractions were stored at 
 

 
70
 

 
C until assayed for retinyl palmitate
(RP).
 
Lipid analysis
 
Cholesterol and triacylglycerols (TGs) in plasma and lipopro-
tein fractions were assayed by enzymatic procedures (19, 20).
apoA-I and apoB were determined by turbidimetry (21). The se-
rum apoE concentration was determined using a kit from Wako
Chemicals. HDL-cholesterol was measured by analyzing the su-
pernatant fluid obtained after precipitation of a plasma aliquot
with dextran sulfate and Mg
 
2
 

 
 as described by Warnick, Bender-
son, and Albers (22). LDL-cholesterol was obtained as the differ-
ence between HDL-cholesterol and the cholesterol from the bot-
tom part of the tube after ultracentrifugation (183,000 
 
g
 
 for 24 h
at 4
 

 
C) at a density of 1.019 kg/l.
 
RP assay
 
The RP content of large and small TRL fractions was assayed
using a method previously described (23). The RP concentration
in each sample was expressed as the ratio of the area under the
RP peak to the area under the retinyl acetate peak (24).
 
Determination of apoB-48 and apoB-100
 
apoB-48 and apoB-100 were determined by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as de-
scribed by Karpe and Hamsten (25). Gels were scanned with a
videodensitometer scanner (TDI, Madrid, Spain) connected to a
personal computer for integration of the signals. Background in-
tensity was calculated after scanning an empty lane. The coeffi-
cient of variation for the SDS-PAGE was 7.3% for apoB-48 and
5.1% for apoB-100.
 
DNA amplification and genotyping
 
Genomic DNA extraction and 
 
apoE
 
 E2/E3/E4 (26) and
 

 
219G/T (7, 8) genotypes were determined as previously de-
scribed. Digested DNA was separated by electrophoresis on an
 
TABLE 1. Plasma lipids and apolipoproteins according to the 
 

 
219G/T 
 
apoE
 
 promoter polymorphism
 
GG (n 
 

 
 14) GT (n 
 

 
 29) TT (n 
 

 
 8)
 
P
 
a
 
Age (years) 23.3 
 

 
 8.0 22.9 
 

 
 4.1 21.5 
 

 
 4.5 0.79
Body mass index (kg/m
 
2
 
) 25.8 
 

 
 2.9 24.6 
 

 
 3.6 26.5 
 

 
 3.9 0.36
Cholesterol (mmol/l) 3.99 
 

 
 0.5 4.05 
 

 
 0.7 3.77 
 

 
 0.5 0.61
Triacylglycerols (mmol/l) 0.90 
 

 
 0.4 0.90 
 

 
 0.4 1.02 
 

 
 0.4 0.78
LDL-cholesterol (mmol/l) 2.35 
 

 
 0.6 2.52 
 

 
 0.6 2.27 
 

 
 0.5 0.50
HDL-cholesterol (mmol/l) 1.29 
 

 
 0.3 1.18 
 

 
 0.3 1.14 
 

 
 0.4 0.43
apoB (g/l) 0.67 
 

 
 0.2 0.68 
 

 
 0.2 0.66 
 

 
 0.2 0.97
apoA-I (g/l) 0.99 
 

 
 0.2 0.99 
 

 
 0.2 0.89 
 

 
 0.1 0.45
apoE (g/l) 0.12 
 

 
 0.04 0.11 
 

 
 0.03 0.09 
 

 
 0.02 0.19
apoB, apolipoprotein B. Values are given as mean 
 

 
 SD.
 
a
 
 
 
Data were tested for statistical significance between genotypes by
analysis of variance (ANOVA).
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8% nondenaturing polyacrylamide gel at 150 V for 2 h. Bands
were visualized by silver staining. Samples containing the T allele
of the 
 

 
219G/T polymorphism were amplified a second time to
verify the genotype.
 
Statistical analysis
 
Several variables were calculated to characterize the postpran-
dial responses of the plasma TGs large TRL and small TRL to
the test meal. The area under the curve (AUC) was defined as
the area between the plasma concentration versus the time curve
and a line drawn parallel to the horizontal axis through the 0 h
concentration. Because the latter time points for plasma apoE
were lower than the 0 h level, the apoE AUC was calculated as
the area between the plasma apoE concentration and the hori-
zontal axis. These areas were calculated by a computer program
using the trapezoidal rule. Other variables were the normalized
peak concentration above baseline and the peak time, which was
the average of the time of peak concentration and the time to
the second highest concentration. Data were tested for statistical
significance between genotypes by ANOVA and the Kruskal-Wal-
lis test, and between genotypes and time by ANOVA for repeated
measures. In this analysis, we studied the statistical effects of the
genotype alone, independent of time, in the postprandial study,
the effect of time alone or change in the variable after ingesting
fatty food over the entire lipemic period, and the effect of the in-
teraction of both factors (genotype and time), which is indicative
of the magnitude of the postprandial response in each group of
subjects. When statistical significance was found, the Tukey post-
hoc comparison test was used to identify group differences. A
probability value of less than 0.05 was considered significant. All
data presented in the text and tables are expressed as means 
SD. SPSS 7.5 for WINDOWS (SPSS Inc., Chicago, IL) was used
for the statistical comparisons.
RESULTS
The baseline characteristics of the subjects are shown in
Table 1. Significant differences were not observed for any
of the variables analyzed in the basal state among subjects
homozygous for the G allele (GG, n  14), subjects het-
erozygous for the T allele (GT, n  29), and subjects ho-
mozygous for the T allele (TT, n  8) of the 219G/T
polymorphism located in the apoE gene promoter region.
The postprandial response of triglycerides, RP, and cho-
lesterol in large TRL is shown in Fig. 1. The fat-loading
test significantly increased triglycerides (P  0.001), RP (P 
0.009), and cholesterol (P  0.001) in both large and
small TRL, with respect to baseline levels, indicating an in-
crease of these parameters in the different groups of sub-
jects during the postprandial period.
The analysis of the interaction between genotype and
time showed that the subjects homozygous for the T allele
have a higher postprandial response of triglycerides (P 
0.001), RP (P  0.005), and cholesterol (P  0.05) in
large TRL than carriers of the G allele (Fig. 1). Further-
more, the AUC of triglycerides (P  0.05), RP (P  0.05),
and cholesterol (P  0.05) in large TRL was greater in
subjects homozygous for the T allele when compared with
carriers of the G allele (Table 2).
apoB-100 and apoB-48 in large and small TRLs were
also analyzed. Significant differences were not found for
the apoB-100 in large or small TRL or for the apoB-48 in
large TRL among the three genotypes studied (Table 2).
However, a significant effect of the interaction between
genotype and time was observed for the apoB-48 levels in
small TRL (P  0.05) (Fig. 2A). Subjects homozygous for
the T allele showed a higher postprandial response of
apoB-48 levels in the small TRL compared with carriers of
the G allele. The intake of fat significantly increased levels
of apoB-48 in the small TRL (P  0.001) with respect to
baseline levels (Fig. 2A). Moreover, the AUC of apoB-48 in
small TRL (P  0.05) was greater in subjects homozygous
for the T allele when compared with carriers of the G al-
lele (Table 2).
When we studied the serum apoE levels, a gradual ef-
fect was observed, whereby the subjects with the TT geno-
Fig. 1. Line plots of postprandial large triacylglycerol-rich lipo-
protein (TRL)-retinyl palmitate (A), large TRL-triacylglycerol (TG)
(B), and large TRL-cholesterol (C) response in TT subjects (n  8,
continuous line, black circles), GT subjects (n  29, discontinuous
line, black triangles), and GG subjects (n  14, discontinuous line,
white circles). The levels at each time point were averaged and ad-
justed to baseline TG (B) and cholesterol (C) for each group. P1:
genotype effect; P2: time effect; P3: genotype by time interaction.
ANOVA for repeated measures. * Indicates statistically significant
differences among genotypes at that specific time point. P  0.05
using the Tukey test. Error bars indicate mean  SD.
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type showed the lowest postprandial levels and subjects
with the GG genotype had the highest levels (P  0.05)
(Fig. 2B). Furthermore, the AUC of serum apoE levels (P 
0.05) was greater in subjects homozygous for the T allele
when compared with carriers of the G allele (Table 2).
However, when we studied the correlation between base-
line plasma apoE levels and the postprandial response
(AUC for triglycerides, RP, cholesterol, apoB-48, and
apoB-100 in small or large TRL), no significant differ-
ences were observed.
DISCUSSION
Our results demonstrate that subjects homozygous for
the T allele of the 219G/T polymorphism located in the
apoE gene promoter region have a higher postprandial re-
sponse of cholesterol, triglycerides, and RP in chylomicrons,
and of apoB-48 in chylomicron remnants. Furthermore,
we have found that the presence of this polymorphism de-
termines serum apoE levels during the postprandial pe-
riod.
Several studies have demonstrated that the presence of
polymorphisms located in the AI-CIII-AIV complex (17,
18) and in other gene loci determines variations in the
postprandial response. Moreover, the effects of variations
in the apoE gene on the absorption and clearance of di-
etary fats are well known (16). For example, clearance of
postprandial particles is delayed in carriers of the E2 allele
compared with carriers of the E4 allele. However, in re-
cent years, it has been suggested that in addition to the
qualitative effect induced by the apoE gene polymor-
phisms, the quantitative changes in gene expression could
also be an important factor in the variability of the post-
prandial state. This hypothesis is backed by the recent dis-
covery of a new polymorphism, 219G/T, located in the
apoE gene promoter region that determines levels of gene
expression.
The influence of this polymorphism on postprandial
lipemic response in healthy subjects remains unknown. In
our study, we have observed that subjects homozygous for
the T allele have a higher postprandial response, with ele-
vated levels of intestinal TRL, as demonstrated by a higher
AUC and higher levels of apoB-48 and RP. Additionally,
we have found a lower AUC and lower serum apoE levels in
TABLE 2. Area under the postprandial curve according to the 219G/T apoE promoter polymorphism
GG (n  14) GT (n  29) TT (n  8) Pa
Total cholesterol (mmol·s/l) 0.75  0.12 0.74  0.14 0.71  0.10 0.87
Triacylglycerols (mmol·s/l) 0.31  0.11 0.31  0.15 0.36  0.16 0.67
LDL-cholesterol (mmol·s/l) 0.41  0.11 0.44  0.14 0.41  0.10 0.74
HDL-cholesterol (mmol·s/l) 0.23  0.05 0.21  0.05 0.21  0.06 0.26
apoB (g·s/l) 0.12  0.03 0.12  0.04 0.12  0.04 0.54
Large TRL-TG (mmol·s/l) 0.10  0.04 0.12  0.07 0.20  0.09 0.031b
Small TRL-TG (mmol·s/l) 0.09  0.05 0.08  0.04 0.09  0.06 0.70
Large TRL-C (mmol·s/l) 0.03  0.01 0.03  0.01 0.05  0.01 0.042b
Small TRL-C (mmol·s/l) 0.05  0.03 0.03  0.02 0.05  0.04 0.81
Large TRL-RP (ng·s/ml) 21.15  12.12 21.84  16.15 51.78  16.01 0.042b
Small TRL-RP (ng·s/ml) 12.30  7.29 11.44  9.47 11.45  8.61 0.97
Large TRL-apoB48 (AU) 319  313 418  322 515  333 0.59
Small TRL-apoB48 (AU) 227  249 482  325 782  384 0.046b
Large TRL-apoB100 (AU) 985  942 615  628 537  217 0.41
Small TRL-apoB100 (AU) 30904  24742 25370  15986 21231  18462 0.70
Serum apoE (g·s/l) 0.023  0.007 0.018  0.005 0.016  0.002 0.048b
TRL, triacylglycerol-rich lipoprotein; RP, retinyl palmitate; AU, arbitrary unit. Values are given as mean  SD 
105, except for apoB48 and apoB100 (mean  SD) in both Large and Small TRL.
a Data were tested for statistical significance between genotypes by ANOVA.
b P  0.05.
Fig. 2. Line plots of postprandial apolipoprotein B-48 (apoB-48)
in small TRL (A) and plasma apoE (B) response in TT (n  8, con-
tinuous line, black circles), GT (n  29, discontinuous line, black
triangles), and GG subjects (n  14, discontinuous line, white cir-
cles). P1: genotype effect; P2: time effect; P3: genotype by time in-
teraction. ANOVA for repeated measures. * Indicates statistically
significant differences among genotypes at that specific time point.
P  0.05 using the Tukey test. Error bars indicate mean  SD.
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subjects with the TT genotype, with significant differences
observed at 4 h, coinciding with the highest peak of post-
prandial lipemia. These differences are in accordance with
the results obtained in other studies that demonstrated
that apoE gene expression was modified by the 219G/T
polymorphism (7). This can be explained by the fact that
the presence of a G instead of a T significantly increases
promoter activity by as much as 169%, as compared with
the controls. Furthermore, a study with a European popu-
lation that included controls and multi-infarct patients
has shown that subjects homozygous for the T allele had
significantly lower baseline plasma levels of apoE than
other subjects (9).
The mechanisms via which the 219T allele of the
apoE gene enhances atherothrombosis are yet to be eluci-
dated. In the study by Lambert et al. (9), the 219G/T
polymorphism did not modify baseline plasma lipid or li-
poprotein concentrations, as in our study. The authors
speculated that the 219TT genotype could increase the
risk of MI at a local level by modifying the macrophage
apoE expression, but experimental data to corroborate
this hypothesis do not exist. Unlike Lambert et al., we de-
signed a postprandial study to investigate the functional
impact of the 219G/T polymorphism because of the im-
portant role of apoE in the uptake of TRL that occurs
in the postprandial state. Several studies have shown that
the apoE in the TRL interacts with different receptors in
the liver, inducing the uptake of these particles from the
bloodstream and their hepatic metabolism (1, 2). It is
probable that lower apoE plasma levels observed in sub-
jects homozygous for the T allele are also associated with
lower apoE-TRL levels, thus reducing clearance by hepatic
receptors. This phenomenon could explain the higher
postprandial response observed in our study, as well as the
increased risk of MI and premature CHD (9, 10) associ-
ated with homozygous carriers of the T allele, owing to
the importance of triglyceride-rich postprandial particles
as a risk factor for atherosclerosis (26, 27).
A limitation of our study is that it includes a relatively
small number of subjects. However, we wanted to include
in our study only young normolipemic apoE 3/3 males in
order to avoid the variable postprandial lipid response of
the other apoE isoforms or gender. Therefore, only 51
healthy apoE 3/3 male volunteers were selected from over
100 subjects.
In conclusion, our data suggest that the –219G/T poly-
morphism located in the apoE gene promoter region may
influence TRL metabolism during the postprandial pe-
riod, thus prolonging postprandial lipemia in subjects
with the TT genotype.
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